Search reports, ask a question, or jump to a page.
The problem
Intervention: Pediatric Tuina (traditional Chinese manual therapy) administered three times weekly for 4 weeks, plus conventional medication
Who it was tested with: Children aged 6-14 years with combined allergic rhinitis and asthma syndrome in remission (n=92, randomized 1:1).
Children or communities are compared with a group that did not receive the intervention, or followed over years. This is the design that best separates what the intervention did from everything else that changed.
"A total of 92 children aged 6-14 years with CARAS in remission will be randomly assigned (1:1) to either the control group (conventional medication) or the intervention group (conventional medication plus pediatric Tuina)." This describes a randomized controlled trial design with comparison groups, meeting criteria for EXPERIMENTAL tier evidence, though the trial is not yet complete.
This is a protocol paper describing a planned study design rather than completed research. No efficacy, safety, or outcome data are available. The results remain pending completion of the trial.
Across countries and designs
1 study · 1 country
